Delayed biliary drainage and inpatient outcomes in pancreatobiliary malignancy: A National Inpatient Sample analysis, 2020-2023.
Abstract
581 Background: Timely biliary decompression is central to inpatient management of malignant biliary obstruction, yet delays may reflect modifiable care-delivery barriers. While early drainage is guideline-recommended for acute cholangitis of benign etiology, the impact of drainage timing in the malignant setting has not been characterized at a national level. We evaluated outcomes and factors associated with delayed drainage among hospitalized patients with pancreatobiliary malignancy. Methods: We used the 2020-2023 National Inpatient Sample to identify adult hospitalizations with pancreatic, gallbladder, intrahepatic cholangiocarcinoma, or extrahepatic biliary cancer, biliary obstruction or cholangitis, biliary drainage procedure, and a non-missing inpatient procedure day that was not before admission or after discharge. Delayed drainage was defined as procedure day 3 or later; early drainage was day 0-2. Survey-weighted regression adjusted for age, sex, payer, income quartile, hospital teaching status, bed size, weekend admission, elective admission, transfer status, cancer subtype, drainage modality, cholangitis, and year. Charge models were restricted to 2020-2022 because 2023 charges were unavailable. Results: The cohort included 20,063 unweighted hospitalizations, representing 100,315 nationally weighted hospitalizations. Delayed drainage occurred in 32.7%. Compared with early drainage, delayed drainage was associated with higher unadjusted mortality (5.2% vs 3.1%), AKI (28.6% vs 20.1%), sepsis (23.7% vs 21.5%), longer mean LOS (10.9 vs 5.7 days), and higher mean charges ($145,392 vs $92,954). After adjustment, delayed drainage was associated with higher mortality (aOR 1.51, 95% CI 1.30-1.77), AKI (aOR 1.53, 95% CI 1.43-1.65), and sepsis (aOR 1.18, 95% CI 1.08-1.28). Mortality association persisted after additional adjustment for sepsis and AKI (aOR 1.33, 95% CI 1.13-1.56). Delayed drainage was associated with 74.0% longer LOS and 48.6% higher charges. Weekend admission (aOR 1.16, 95% CI 1.08-1.25) and Medicaid insurance (aOR 1.26, 95% CI 1.11-1.42) were associated with delay. In 2020-2022 sensitivity analyses, Black and Hispanic patients had higher odds of delayed drainage. Results were robust after excluding other/unclear modality and restricting to non-stone obstruction/cholangitis. Conclusions: Delayed biliary drainage occurred in one-third of hospitalizations for pancreatobiliary malignancy with obstruction/cholangitis and was associated with worse clinical and resource outcomes. Drainage timing may represent a modifiable inpatient oncology quality metric with operational and equity implications.